Loading...
Loading...
Dermatology Billing Services
Recover the Revenue Lost to Cosmetic-vs-Medical Misclassification, Lesion Coding Errors, and Pathology Billing Gaps.
What Dermatology Billing Actually Requires
Dermatology billing requires specialty coders who can defend medical necessity on procedures payers assume are cosmetic, code lesion excisions and destructions by size and pathology result, split pathology billing between professional and technical components, and clear prior authorization on biologics before the drug is administered. Qualigenix handles all of it and holds a 98.2% first-pass clean claim rate on first submission across the book of work.
01
Medical vs. Cosmetic Classification - The Billing Line Payers Scrutinize Most
A benign lesion removal, a scar revision, or a laser treatment can be medically necessary or cosmetic, and the payer decides based on your documentation, not your intent. Misclassify it and you get a denial, a patient dispute, or a compliance flag. Every one of those is a claim you already did the work for.
02
Lesion Removal, Destruction & Multiple-Lesion Coding Complexity
Excision codes depend on lesion size, location, and whether it's benign or malignant, and destruction codes turn on the count and the diagnosis. Reporting multiple lesions on one visit without the right primary and add-on structure downcodes the whole claim.
03
Prior Auth: Biologics, Phototherapy & Laser
Biologics for psoriasis, atopic dermatitis, and hidradenitis suppurativa, plus phototherapy and some laser procedures, need payer approval before treatment. Administer first and the claim gets denied with no clean path to appeal.
04
Pathology Billing: PC/TC Splits & Outside Labs
Most dermatology procedures generate a specimen, and each one carries a professional and a technical component that bill differently depending on whether you read it in-house or send it out. Miss the split or the specimen tracking and the pathology revenue disappears.
05
Modifier Management: Sites, Distinct Services & Staged Care
Dermatology claims lean hard on modifiers to separate distinct procedural services, multiple anatomical sites, bilateral work, and staged treatments. Wrong modifier, denied claim. It's one of the top rejection reasons in the specialty.
06
J-Code Reporting & Specialty Drug Acquisition Costs
When you buy and administer a biologic, you have to report the J-code accurately, account for drug acquisition cost, and coordinate with specialty pharmacy. Errors here don't just delay payment, they mean you eat the cost of the drug.
07
Documentation, Lesion Measurement & Medical Necessity
Excision size, lesion count, treatment plan, and pathology findings all have to be in the note to support the code you billed. Thin documentation is the fastest route to a medical-necessity denial.
08
Denial Management - Dermatology's Top Rejection Reasons
Medical-necessity denials, cosmetic exclusions, modifier errors, authorization gaps, and coding inaccuracies stack up fast in dermatology, and most practices don't have the staff hours to work them before the filing window closes.
How Qualigenix Closes Each Dermatology Revenue Gap
Qualigenix assigns dermatology-specialty coders to your account and works each gap above in the same order, so nothing gets handed to a generalist. Here's what that looks like.
Accurate Coding & Charge Capture
Specialty coders assign excision, biopsy, destruction, and repair codes by size, count, and pathology result, so the claim reflects the work and holds up on review. Qualigenix runs a 98.9% coding accuracy rate.
Medical-Necessity Classification & Cosmetic Carve-Out
We document and code the medical-vs-cosmetic line before the claim goes out, so medically necessary procedures aren't lost to cosmetic exclusions and genuinely cosmetic work is handled as self-pay from the start.
Prior Authorization Management
We secure authorization on biologics, phototherapy, and advanced laser procedures before treatment, so the claim isn't dead on arrival.
Pathology Billing Coordination
We track specimens and split professional and technical components correctly, whether you read in-house or send to an outside lab, so the pathology revenue actually gets billed.
Modifier & Multiple-Procedure Accuracy
We apply the right modifiers for distinct services, multiple sites, bilateral, and staged procedures, which is where a large share of dermatology denials start.
Biologic & J-Code Drug Billing Support
We report J-codes accurately, account for acquisition cost, and coordinate specialty pharmacy, so administered drugs get reimbursed.
Clinical Documentation Support
We flag notes that won't support the billed code before submission, so lesion size, count, and medical necessity are on the record.
Denial Management & Appeals
We work denials to root cause and appeal fast. Qualigenix overturns 79% of denials across 50,000 denials worked per month.
CASE STUDY 01
How A Mohs Practice Recovered $74K In Underbilled Stages And Blocks
THE SITUATION
Mohs stages and tissue blocks (first stage 17311/17313, additional 17312/17314, additional blocks 17315) were miscounted, both over- and under-reported. Additional-stage add-ons were billed without the correct first-stage primary, block counts didn't match the op note, and same-day repairs were bundled incorrectly, leaving unit-error denials at 19% across ~150 Mohs cases a quarter.
WHAT QUALIGENIX DID
We built a Mohs mapping worksheet that reconciled stages and blocks to the operative note before billing and validated repair-code separability.
Key Outcomes & Turnaround
19% to 3.5%Denial rate
$74,000Revenue Recovered
87% to 96%Net collection rate
150/qtr (Mohs cases)Volume worked
Audited Practice Results
How A General Dermatology Practice Aged A/R 15 Days Faster On Lesion Claims
THE SITUATION
Post-2019 biopsy codes require a primary technique code (11102/11104/11106) with technique-specific add-ons, and benign vs premalignant destruction counts (17110/17111 vs 17000/17003/17004) were mis-tiered. Add-on biopsies were billed without the matching primary and lesion counts landed in the wrong tier, holding add-on denials at 16% and A/R at 49 days across ~2,200 encounters a quarter.
WHAT QUALIGENIX DID
We deployed a biopsy-technique matcher that paired each add-on to its correct primary, and a lesion-count calculator that routed destructions into the correct tier and code family.
Key Outcomes & Turnaround
16% to 3%Denial Rate
49 to 34 daysDays in AR
80% to 96%Clean Claim Rate
~2,200/qtr (lesion encounters)Volume worked
Audited Practice Results
How A Dermatology Practice Turned $45K Of Write-Offs Into Collectible Balances
THE SITUATION
Services on the medical/cosmetic border (benign lesion removal, certain destructions) were denied as non-covered without an ABN, leaving balances unbillable to the patient. Qualifying diagnosis and size/location documentation were missing, no ABN was captured for likely-non-covered services, and cosmetic services were filed to insurance in error, with $54,000 sitting as uncollectible leakage.
WHAT QUALIGENIX DID
We added a coverage pre-check that flagged likely-non-covered services and triggered ABN capture at check-in, plus a diagnosis/documentation prompt to support medical-necessity claims.
Key Outcomes & Turnaround
18% to 5%Denial Rate
$45,000Revenue Recovered
85% to 94%Net collection rate
ABN at check-inProcess Fix
Audited Practice Results
Dermatology Coding Built Around Your Service Lines
Qualigenix codes each dermatology service line to its own code family, not a generic template. These are the lines we bill most.
Lesion Excision - Benign & Malignant (11400–11646)
Coded by lesion size and whether benign or malignant, with the correct primary-plus-add-on structure when multiple lesions are removed in one visit.
COMPLIANCE
How We Keep Dermatology Billing Services Billing Compliant
0%
Audit Pass Rate
<0%
Variance Threshold
Why Qualigenix
0%
Net Collection Rate
0
Days in AR
0%
Denials Overturned
0%
Clean Claim Rate
Frequently Asked Question
Dermatology Billing FAQs
Most dermatology billing is priced as a percentage of collections, so the fee scales with what Qualigenix actually collects for you, not a flat retainer. The right comparison isn't the fee, it's the fee against the revenue recovered from cleaner claims and worked denials. Ask for a free A/R review and we'll show the math on your own numbers. Call 786-259-0231.
We code and document the medical-necessity line before the claim goes out, so medically necessary lesion removals, scar work, and laser treatments aren't lost to cosmetic exclusions, and genuinely cosmetic procedures are set up as self-pay from the start. This is the single biggest denial driver in dermatology, and it's the first thing we fix.
We track each specimen and split the professional and technical components correctly, whether you read pathology in-house or send it to an outside lab, so pathology revenue is billed instead of dropped.
Yes. We take over aged A/R and work it alongside current claims, so the backlog gets collected instead of written off. Most dermatology practices start with a free A/R review so you can see what's recoverable before committing.
We secure authorization before treatment for biologics, phototherapy, and advanced laser procedures, so the claim isn't denied for a missing auth after the drug is already administered. We track auth status against the treatment schedule so nothing gets billed ahead of approval.
Yes. Dermatology-specialty coders assign excision codes (11400–11646) by lesion size and malignancy, and Mohs codes (17311–17315) by stage and block count, with the documentation the payer needs to hold the claim. Qualigenix runs a 98.9% coding accuracy rate.
Almost certainly. Qualigenix bills inside dermatology systems like ModMed EMA, Nextech, and EZDERM, and supports 133 EMR/EHR platforms in total. We work in your system, so switching billing partners doesn't mean switching software.
Qualigenix onboards in a 6-day average. We map your EMR, payers, and specialty coding rules up front so billing keeps moving through the transition rather than stalling.